Most patients with bowel cancer not advised to exercise despite its health benefits
the ONA take:
Many patients with bowel cancer say they were not advised to exercise regularly after diagnosis. Exercise can help ease fatigue, depression, and anxiety; is linked to better survival and better quality of life for patients; and reduces the risk of recurrence.
However, a Cancer Research UK study has shown that many patients are not advised to be more active.
The researchers asked more than 15,000 patients with bowel cancer about their current level of exercise and whether they were advised to be more active.
Only 31% said they were advised to exercise at any point during their treatment, 69% said they were not advised at all.
Current NHS guidelines recommend that healthy people get at least 2.5 hours of moderate physical activity per week.
Although no guidelines specific to patients with bowel cancer are in place, the researchers recommend that patients discuss exercise with their doctor and get advice on what is safe for them and suits their lifestyle and ability.
Many patients with bowel cancer say they were not advised to exercise regularly after diagnosis.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|